Introduction 57
Although many viruses are able to enter the nervous system, only a limited set of viruses has evolved 58 specific mechanisms for directed axonal transport to ensure neuroinvasion and virus replication in the 59 peripheral and central nervous system (CNS) (1). Among those viruses, rabies virus (RABV; 60 rhabdoviridae family) is a classic example of a pathogen that enters the nervous system by retrograde 61 axonal transport. Though retrograde and anterograde transport of any cargo within the axon of a neuron 62 depend on microtubules and associated motor complexes (2), detailed knowledge about checkpoints 63 regulating the directionality of virus transport processes in neurons remain limited. 64
RABV is a non-segmented negative-strand RNA virus that is transmitted from rabid animals by bites. 65
The virus is transported through retrograde microtubule dependent axonal transport (3) from the site of 66 inoculation to the CNS, where virus replication is accompanied with progressive neuronal dysfunctions 67 and lethal outcome of the disease. The genome of rabies virus encodes five virus proteins: 68 nucleoprotein N, phosphoprotein P, matrix protein M, glycoprotein G and large polymerase L. Rabies 69 virus replication requires a ribonucleoprotein (RNP) complex consisting of the genomic virus RNA 70 tightly packaged by nucleoprotein. Phosphoprotein P is associated with the RNP in chaperoning N to 71 ensure specific RNA packaging and as polymerase co-factor within the P/L-polymerase complex. 72
Identification of a dynein light chain 1 (DLC1) binding motif in the rabies virus phosphoprotein (4, 5) 73 supported the hypothesis, that RABV RNPs directly bind to dynein motor complexes and thus enter the 74 retrograde transport pathway after release from endosomes. Subsequent studies revealed that 75 destruction of the DLC1 binding motif in P did not abrogate the ability of RABV to invade the CNS (6) 76 but had a supportive effect on early virus transcription (7). 77
Fluorescence protein fusion to P has been used to label RNPs of RABV (8, 9) and other rhabdoviruses 78 neurons by trypsin treatment for 20 min at 37 °C, neurons were cultivated in Neurobasal medium with 160 B27-supplement, GlutaMax (all Invitrogen), Penicillin/Streptomycin (Sigma-Aldrich) and nerve 161 growth factor 2.5S (50 ng/ml; Invitrogen). The neuron cultures were incubated at 37 °C and neuronal 162 medium was replaced every 3 days. 163
Compartmentalized neuron culture. After coating of µ-Slide 6 0.4 cultivation chambers (Ibidi) with 164 poly-DL-ornithine (500 µg/ml; Sigma-Aldrich) and natural mouse laminin (10 µg/ml; Invitrogen), the 165 channels of the µ-Slide connecting the two opposite chambers were filled with 30 µl of 0.5% agarose 166 in Neurobasal medium. After agarose polymerization, the two chambers were filled with Neurobasal 167 medium and 30µl of a DRG neurons suspension containing cells from 2.5 dorsal root ganglia were 168 seeded into the "proximal" chamber. After cultivation over night at 37 °C, 40 µl medium were removed 169 from the chambers and replaced by the same volume of Neurobasal medium with 10 µM 170
Arabinofuranosyl Cytidine (Ara C). After 3 days of Ara C-treatment, the medium was replaced with 171 Ara C-free medium and the neurons were further cultivated for 2 to 3 weeks. 172
Indirect immunofluorescence and live virus imaging. Indirect immunofluorescence with mouse 173 monoclonal antibody E559 (35) recognizing RABV G protein and AlexaFluor 568 conjugated 174 secondary antibodies (Molecular Probes) was performed by standard techniques after fixation with 3.7 175 % formaldehyde in PBS and permeabilization with 0.5 % Triton-X100 in PBS . Images were acquired 176 with a Leica SP5 confocal laser scan microscope (63x objective; numerical aperture: 1.4) with 177 sequential acquisition of the fluorophores in double fluorescent specimen. Images were processed with 178 the ImageJ software version 1.48b (36). 179
Live imaging of neuronal cultures was performed at 37 °C on a Leica SP5 confocal laserscan 180 microscope equipped with a resonant scanner for fast image acquisition. Images were acquired at frame 181 rates indicated in the results section. To achieve better particle detection, in some experiments the 182 
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RABV infection and live imaging of DRG neurons. To study RABV axonal transport we established 193 a compartmental platform as described in the Material and Methods. DRG neurons were cultured from 194 15.5 days old rat embryos and the cells were seeded into the proximal chamber of the 195 compartmentalized channel slides ( Figure 1A ). To prevent movement of cell bodies towards the 196 opposite culture chamber, the connecting channels were filled with 0.5 % agarose as a diffusion barrier. 197
Neurons were cultivated for two weeks and axon outgrowth through the 1.7 cm long channels towards 198 the opposite distal chamber was regularly controlled by microscopy. In addition, the absence of cell 199 bodies in channels and distal medium reservoirs was verified. 200
When axon growth cones reached the distal chamber after two weeks, neurons were infected at the 201 axon endings with 10 4 focus forming units (ffu) of recombinant RABV expressing EGFP-tagged 202 phosphoprotein P. In addition to the EGFP, the recombinant virus rRABV EGFP-P DLC1mut Gcvs 203 ( Figure 1B ) contained a mutation in the dynein light chain 1 (DLC1) binding motif of P. Moreover, the 204 glycoprotein G of the attenuated RABV backbone was replaced by a G sequence of the pathogenic 205 CVS-11 strain. Whereas the glycoprotein replacement was intended to increase neuroinvasive 206 properties to the attenuated rRABV backbone (9), the DLC1 binding mutation was inserted to exclude 207 any effect of dynein motor complex binding of incoming RNPs during entry and the intracellular 208 transport of newly formed RNPs after virus replication in the infected neuron. 209
Infection of DRG neurons was monitored by GFP fluorescence. After one day of infection, green 210 fluorescence in proximal cell bodies and in axons (not shown) was detectable. After 2 to 5 days of 211 infection, the neurons were completely filled with EGFP-tagged P protein and axonal transport of 212 EGFP-P particles in both directions was observed. Bundles of parallel fluorescent axons were detected 213 in the channel, whereas infected cell bodies remained exclusively in the proximal chamber ( Figure 1B protein complexes in axons, we investigated, whether EGFP labeled phosphoprotein of NDV is also 265 transported into axons after NDV replication and EGFP-P-particle formation in the neurons cytoplasm. 266
In contrast to RABV, NDV only occasionally infects the CNS (37) and we considered the existence of 267 specific motifs in NDV mediating axonal transport of NDV particles as unlikely. After 4 days of 268 infection at the cell soma with RABV EGFP-P Gcvs or rNDVF1 EGFP-P, GFP fluorescence was 269 monitored in the cell soma, in a proximal area within the channel close to the cell soma (~1 mm 270 relative to proximal chamber) and in a distal part (~12 mm relative to proximal chamber) of the 271 channel ( Figure 5 ). Both viruses led to the accumulation of strong GFP-fluorescent cytoplasmic 272 inclusions, indicating that both viruses successfully infected the DRG neurons at the cell soma. In 273 contrast to RABV EGFP-P, where small EGFP-P particles were detected in outgrowths of the neurons, 274 in rNDVF1 EGFP-P infected cultures, particulate EGFP-P fluorescence was restricted to the cell soma 275 and only a faint, unequally distributed GFP-fluorescence was detectable in neuritic outgrowths (see 276 Figure 5 , proximal chamber, brightened area). In the channels, NDV-infected neurons only led to a 277 faint axoplasmic GFP fluorescence that decreased from the more proximal to the more distal part of the 278 channel ( Figure 5 , proximal and distal area). Particulate structures were absent in the axons, showing 279 that rNDVF1 EGFP-P particles do not enter the axonal transport machinery. In contrast to rNDVF1 280 EGFP-P, infection with RABV EGFP-P resulted in the appearance of particulate structures in proximal 281 and distal parts of the axons. These data support the idea, that in the used DRG neuron cultures specific 282 axonal sorting occurs. Accordingly, we assume that GFP-labeled RABV particles are not randomly 283 transported through axons, for instance as a result of abundant protein levels, but that specific 284 mechanisms exist that allow intra-axonal transport of RABV particles into the anterograde direction. Whereas in close proximity to the soma some EGFP-P particles were detected, images from mid parts 297 of the channels revealed that in the absence of G only diffuse GFP fluorescence was detectable in the 298 axons, indicating that no EGFP-P-particles entered the anterograde transport pathway (Figure 6 ). In 299 contrast, RABV EGFP-P Gcvs led to intra-axonal transport of EGFP-P particles. 300
These data strongly suggested the axonal transport of glycoprotein containing virus particles or at least 301 co-transport of EGFP-P particles and vesicles of the cellular transport machinery containing RABV-G. 302
Moreover, dependence of the anterograde axonal transport on newly synthesized G also excluded the 303 possibility that the observed EGFP-P particles in the axons were due to an accumulation of input virus. 304
Colocalization of P particles with glycoprotein. To assess whether G-dependent axonal transport of P 305 particles correlated with colocalization of G and P, DRG neuron cultures were infected with rRABV 306 EGFP-P Gcvs at the cell soma. After 2 days of infection the DRGs were fixed and immunostained with 307 G-specific Mab E559. Detection of EGFP-P particles and G vesicles ( structures. In addition, non-colocalized EGFP-P and G particles were also observed in the distal 311 chamber (arrows). Due to the deletion of G, neither EGFP-P particles nor G signals were detected in 312 distal axon parts of rRABV EGFP-P ΔG infected DRGs (Figure 7, g-i) , whereas diffusely distributed 313 axoplasmatic GFP-fluorescence still indicated presence of soluble EGFP-P protein even at distal parts 314 of the axons. These data indicated that G and EGFP-P particles indeed accumulated in distal axon 315 regions either as a result of co-transport through neurons or of particle assembly at distal membrane 316 sites. As transport of EGFP-P particles depended on the presence of G, we hypothesized that co-317 transport of both viral proteins components was causative for the observed colocalization. Some non-318 colocalizing particles may be due to the additional transport of G-containing secretory vesicles in the 319 case of red particles, and partial dissociation of G and EGFP-P from co-transported particles at distal 320 sites. was not constant over time ( Figure 8C ; Figure S4 ), suggesting that the mCherry-labeled membrane was 339 not as tightly bound to the EGFP-P particle as may be expected in the case of complete bullet shaped 340 RABV particles. Nevertheless, these data strongly supported the hypothesis that anterograde axonal 341 transport of EGFP-P particles either occurs in or at RABV glycoprotein containing membrane vesicles. RABV transport during entry (Fig. 2) and after virus replication in the cell (Fig. 3) due to the use of different cellular motor proteins or to species-specific differences in the velocity of 384 axonal transport in DRGs derived from rat or chicken embryos. The same reasons may also contribute 385 to minor differences in retrograde RABV transport velocities in murine DRG neurons. In the murine 386 DRG neurons, the average velocity of retrograde RABV transport 0.93 µm / sec (12) remained below 387 the velocities of 1.5 µm/sec and 1.6 µm/sec as observed here for retrograde axonal RABV transport in 388 the rat DRG neurons (Figs. 2 and 3) . Notably, also in the murine system, subpopulations of fast RABV 389 transport were identified with velocities of 1.2 to 1.4 µm/sec (12), indicating that also in the murine 390 system RABV can achieve transport kinetics similar to those observed here in the rat DRG system. 391 were infected at the cell soma with rRABV EGFP-P Gcvs and recombinant NDV expressing EGFP-676 tagged NDV P protein (rNDVF1 EGFP-P). EGFP-P fluorescence was monitored at 4 dpi within the cell 677 soma (proximal chamber) and in the channel at proximal areas close to the cell soma side (middle row) 678 and in more distant distal areas (bottom row). Note: brightness/contrast was increased (B/C set to 100) 679 for rNDVF1 EGFP-P fluorescence within the image section (cell soma) and in images from channel 680 areas. 681 
